Mechanism of Inhibition of Immunoglobulin G-Mediated Phagocytosis by Monoclonal Antibodies That Recognize the Mac- 1 Antigen

Total Page:16

File Type:pdf, Size:1020Kb

Mechanism of Inhibition of Immunoglobulin G-Mediated Phagocytosis by Monoclonal Antibodies That Recognize the Mac- 1 Antigen Mechanism of inhibition of immunoglobulin G-mediated phagocytosis by monoclonal antibodies that recognize the Mac- 1 antigen. E J Brown, … , J F Bohnsack, H D Gresham J Clin Invest. 1988;81(2):365-375. https://doi.org/10.1172/JCI113328. Research Article We have investigated the effects of the monoclonal antibodies against the cell surface molecule Mac-1 on C3bi-mediated rosetting and IgG-mediated rosetting and phagocytosis by human peripheral blood monocytes. Highly purified M1/70 F(ab')2, used in the fluid phase, inhibited both monocyte functions. Half-maximal C3bi rosette inhibition occurred at a concentration of 2 nM F(ab')2 M1/70. An equivalent decrease in IgG-mediated rosetting required 10 nM M1/70 F(ab')2, and 50% inhibition of IgG-mediated phagocytosis required 7 nM antibody. Mo-1 F(ab')2 inhibited EC3bi binding with an ID50 of 0.3 nM, whereas 50% decrease in IgG-mediated rosetting required 70 nM of this antibody. OKM1 did not inhibit rosettes of sheep erythrocytes opsonized with IgG antibody (EA) at all. F(ab')2 M1/70 did not affect the binding of monomeric human IgG to monocytes, but did substantially decrease the binding of IgG aggregates. Half-maximal inhibition of aggregated IgG binding at 0 degrees C occurred at 8 nM F(ab')2 M1/70, very close to the concentration that caused equivalent inhibition of IgG-mediated phagocytosis. Aggregated IgG inhibited the binding of radiolabeled M1/70 to monocytes by approximately 40%, suggesting that some, but not all Mac-1 molecules were associated with IgG receptors under these conditions. When cells were allowed to adhere to surfaces coated with M1/70 or Mo-1 F(ab')2, C3bi- mediated rosetting was inhibited, but IgG mediated-phagocytosis was unaffected. Moreover, the dose response of […] Find the latest version: https://jci.me/113328/pdf Mechanism of Inhibition of Immunoglobulin G-mediated Phagocytosis by Monoclonal Antibodies That Recognize the Mac-1 Antigen Eric J. Brown, John F. Bohnsack, and Hattie D. Gresham Departments ofMedicine, and Microbiology and Immunology, Washington University School ofMedicine, St. Louis, Missouri 63110 Abstract tion apparently occurs because of antibody binding to a sub- population of Mac-i molecules which are associated with IgG We have investigated the effects of the monoclonal antibodies Fc receptors and remain on the apical membrane of monocytes against the cell surface molecule Mac-i on C3bi-mediated ro- adherent to anti-Mac-l-coated surfaces. We suggest that setting and IgG-mediated rosetting and phagocytosis by there may be two functionally distinct molecules on human human peripheral blood monocytes. Highly purified M1/70 monocytes recognized by M1/70 and Mo-1 that can be distin- F(ab')2, used in the fluid phase, inhibited both monocyte func- guished by their mobility in the plane of the monocyte mem- tions. Half-maximal C3bi rosette inhibition occurred at a con- brane. The more mobile form of Mac-i is involved in C3bi centration of 2 nM F(ab')2 Mi/70. An equivalent decrease in rosettes, and does not affect IgG-mediated phagocytosis. The IgG-mediated rosetting required 10 nM M1/70 F(ab)2, and other antigen recognized by Mi/70 does not diffuse within the 50% inhibition of IgG-mediated phagocytosis required 7 nM plane of the membrane; ligation of the latter molecule by anti- antibody. Mo-i F(ab'h inhibited EC3bi binding with an ID5s of body is associated with inhibition of IgG-mediated phagocy- 0.3 nM, whereas 50% decrease in IgG-mediated rosetting re- tosis. quired 70 nM of this antibody. OKMi did not inhibit rosettes Introduction of sheep erythrocytes opsonized with IgG antibody (EA) at all. F(ab')2 M1/70 did not affect the binding of monomeric human The mAb M1/70 recognizes a two-chain, cell surface glyco- IgG to monocytes, but did substantially decrease the binding of protein on mouse and human leukocytes termed Mac- I (1, 2). IgG aggregates. Half-maximal inhibition of aggregated IgG This antigen is a member of a family of cell surface molecules binding at 0°C occurred at 8 nM F(ab)2 Mi/70, very close to which are heterodimers of noncovalently linked polypeptides. the concentration that caused equivalent inhibition of IgG-me- Although each member of the family has a unique a chain, the diated phagocytosis. Aggregated IgG inhibited the binding of 3 chains of all these molecules are apparently identical. The radiolabeled M1/70 to monocytes by 40%, suggesting that Mac- I antigen is expressed on granulocytes, monocytes, natu- some, but not all Mac-i molecules were associated with IgG ral killer cells, and some B and T lymphocytes and has been receptors under these conditions. functionally identified with the type 3 complement receptor When cells were allowed to adhere to surfaces coated with (CR3)' and the iC3b receptor (3). M1/70 and certain other M1/70 or Mo-i F(ab32, C3bi-mediated rosetting was inhib- antibodies that recognize Mac-i inhibit the binding of iC3b- ited, but IgG mediated-phagocytosis was unaffected. More- coated erythrocytes (EC3bi) to leukocytes. Moreover, cells over, the dose response of inhibition of phagocytosis by fluid- from patients lacking this membrane antigen fail to rosette phase F(ab')2, of anti-Mac-i monoclonals was similar on with EC3bi. monocytes adherent to albumin-coated and antibody-coated Some studies have attributed other inhibitory properties to surfaces. Kinetic experiments showed that even prolonged in- monoclonal antibodies against Mac-1. Arnaout et al. (4) cubation of monocytes on M1/70 coated surfaces did not lead showed that the IgG2a mAb Mo-I (which recognizes Mac-i) to inhibition of EA binding nor did these incubations alter the and its Fab fragment inhibited IgG-Fc receptor-mediated pha- dose response for inhibition of EA binding by fluid-phase gocytosis as well as EC3bi rosetting (4). We have shown that M1/70 F(ab')2. This suggested that not all molecules recog- M 1/70 inhibited the binding of fibronectin-coated micro- nized by M1/70 are freely mobile in the plasma membrane. spheres to monocytes and PMN (5), and Ezekowitz et al. (6) Indeed, only 60% of 125I-Ml/70-biding sites were lost even have shown that Mo- I and M 1/70 inhibited zymosan binding after 4 h when monocytes were adherent to Ml/70-coated sur- to monocytes and macrophages. Similar inhibition of zymo- faces. We conclude that some anti-Mac-i antibodies can in- san phagocytosis has been found by Ross et al. (7), who hibit EA binding because of their epitope specificity, indepen- showed that some anti-Mac-I mAb also could inhibit the in- dent of any direct interaction with monocyte Fc receptors. This gestion of unopsonized rabbit erythrocytes. These studies sug- interference with IgG-Fc receptor-mediated binding and inges- gest that Mac- I plays an important role in the general adhesive properties of leukocytes, since it is unlikely that each of these inhibitory properties of the anti-Mac-I antibodies can be Dr. Bohnsack's current address is Department ofImmunology, Scripps a interaction. Clinic and Research Foundation, La Jolla, CA 92037. Address reprint ascribed to disruption of single receptor-ligand requests to Dr. Brown, Campus Box 8051, Washington University This hypothesis is supported by studies in patients deficient in School of Medicine, 660 South Euclid Avenue, St. Louis, MO 631 10. Mac-1. These patients' cells exhibit impaired chemotaxis, ag- Received for publication 23 October 1986 and in revised form 11 gregation, and substrate adherence in addition to their inabil- May 1987. ity to rosette with iC3b-coated particles. J. Clin. Invest. 1. Abbreviations used in this paper: AI, attachment index; CR3, com- © The American Society for Clinical Investigation, Inc. plement receptor 3; EA, erythrocytes (sheep) opsonized with IgG anti- 0021-9738/88/02/0365/11 $2.00 body; EC3bi, erythrocytes (sheep) opsonized with iC3b receptor; PI, Volume 81, February 1988, 365-375 phagocytotic index. Functionally Different Mac-1 Molecules 365 In this study we have examined the mechanism by which 2 anti-Mac-i antibodies interfere with cellular functions not obviously dependent on soluble ligand interactions with the 20)C- - Mac-i molecule. We have studied the inhibition of IgG-me- - diated rosetting and phagocytosis by M 1/70 and Mo-I in de- 42 a- tail. We have shown that both Mo-I and M 1/70 F(ab')2, which Figure 1. F(ab')2 M1/70. Lane 1, IgG Ml/70 do not interact at all with monocyte Fc receptors, inhibit IgG- after Biogel AO.5M chromatography with in- mediated erythrocyte binding and phagocytosis. Binding stud- tact IgG and one major contaminant. Lane ies with monomeric and multimeric IgG showed that M 1/70 2, the final preparation of F(ab')2 M 1/70, inhibited multimeric IgG binding while having no effect on containing no visible intact IgG. Proteins monomeric IgG binding to the Fc receptor. Aggregated IgG were electrophoresed on 5-15% gradient was able to inhibit the binding of '251-M1/70 to monocytes by SDS-PAGE under nonreducing conditions. almost 40%, while it had no effect on the binding of mono- clonal anti-CRi . This suggested that some, but not all Mac- I chromatography on Ultragel ACA 54 (Spectrum Medical, Los Angeles, molecules were associated with IgG Fc receptors. By adhering CA). Mo- I F(ab')2 showed a single band on SDS-PAGE. IgG of the monoclonal anti-CR 1 3D9 was purified as described M1/70 F(ab')2 to surfaces, we have been able to distinguish (14). OKM 1 was purchased from Ortho Diagnostics, Raritan, NJ.
Recommended publications
  • Immunoglobulin G Is a Platelet Alpha Granule-Secreted Protein
    Immunoglobulin G is a platelet alpha granule-secreted protein. J N George, … , L K Knieriem, D F Bainton J Clin Invest. 1985;76(5):2020-2025. https://doi.org/10.1172/JCI112203. Research Article It has been known for 27 yr that blood platelets contain IgG, yet its subcellular location and significance have never been clearly determined. In these studies, the location of IgG within human platelets was investigated by immunocytochemical techniques and by the response of platelet IgG to agents that cause platelet secretion. Using frozen thin-sections of platelets and an immunogold probe, IgG was located within the alpha-granules. Thrombin stimulation caused parallel secretion of platelet IgG and two known alpha-granule proteins, platelet factor 4 and beta-thromboglobulin, beginning at 0.02 U/ml and reaching 100% at 0.5 U/ml. Thrombin-induced secretion of all three proteins was inhibited by prostaglandin E1 and dibutyryl-cyclic AMP. Calcium ionophore A23187 also caused parallel secretion of all three proteins, whereas ADP caused virtually no secretion of any of the three. From these data and a review of the literature, we hypothesize that plasma IgG is taken up by megakaryocytes and delivered to the alpha-granules, where it is stored for later secretion by mature platelets. Find the latest version: https://jci.me/112203/pdf Rapid Publication Immunoglobulin G Is a Platelet Alpha Granule-secreted Protein James N. George, Sherry Saucerman, Shirley P. Levine, and Linda K. Knieriem Division ofHematology, Department ofMedicine, University of Texas Health Science Center, and Audie L. Murphy Veterans Hospital, San Antonio, Texas 78284 Dorothy F.
    [Show full text]
  • What Are Immunoglobulins? by Michelle Greer, RN
    CLINICAL BRIEF What Are Immunoglobulins? By Michelle Greer, RN THE IMMUNE SYSTEM is a complex the body such as bacteria or a virus, or in antigen, it gives rise to many large cells network of cells, tissues and organs that cases of transplant, another person’s known as plasma cells. Every plasma cell protect the body from bacteria, virus, organ, tissue or cells. Antigens are identi - is essentially a factory for producing an fungi and other foreign organisms. The fied by the immune system by a marker antibody. 1 Antibodies are also known as primary functions of the immune system molecule, which enables the immune immunoglobulins. Antibodies, or immuno- are to recognize self (the body’s own system to differentiate self from nonself. globulins, are glycoproteins made up of healthy cells) from nonself (anything Lymphocytes (natural killer cells, T cells light chains and heavy chains shaped like foreign), keep self healthy and destroy and B cells) are one of the subtypes of a Y (Figure 1). The different areas on and eliminate nonself. Immunoglobulins white blood cells in the immune system. these chains have different functions and take the lead in this process. B cells secrete antibodies that attach to roles in an immune response. antigens to mark them for destruction. A Review of Terminology Antibodies are antigen-specific, meaning Types of Immunoglobulins Understanding a few related terms and one antibody works against a specific There are several types of immunoglob - their function can provide a better appre - type of bacteria, virus or other foreign ulins and each has a different role in an ciation of immunoglobulins and how substance.
    [Show full text]
  • The Immunoglobulin G Subclass Composition of Immune Complexes in Cystic Fibrosis
    The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion. D B Hornick, R B Fick Jr J Clin Invest. 1990;86(4):1285-1292. https://doi.org/10.1172/JCI114836. Research Article It has been shown that pulmonary macrophage (PM) phagocytosis of Pseudomonas aeruginosa (PA) is inhibited in the presence of serum from cystic fibrosis (CF) patients colonized by Pseudomonas, and that these sera contain high concentrations of IgG2 antibodies. The goal of these studies was to investigate the role that IgG2-containing immune complexes (IC) play in this inhibition of both PM and neutrophil phagocytosis. We found that serum IgG2 concentrations were elevated significantly in CF patients with chronic PA colonization and that in selected sera from CF patients with chronic PA colonization (CF + IC, n = 10), the mean IC level was significantly elevated (2.90 +/- 0.22 mg/dl [SEM]). IgG2 comprised 74.5% of IgG precipitated in IC from CF + IC sera. An invitro phagocytic assay of [14C]PA uptake using CF + IC whole-sera opsonins confirmed that endocytosis by normal PM and neutrophils was significantly depressed. Removal of IC from CF + IC sera resulted in significantly decreased serum IgG2 concentrations without a significant change in the other subclass concentrations, and enhanced [14C]PA uptake by PM (26.6% uptake increased to 47.3%) and neutrophils (16.9% increased to 52.6%). Return of the soluble IgG2 IC to the original CF sera supernatants and the positive control sera resulted in return of the inhibitory capacity of the CF + IC sera.
    [Show full text]
  • Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response
    Journal of Patient-Centered Research and Reviews Volume 4 Issue 3 Article 5 8-10-2017 Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response Michael A. Thompson Martin K. Oaks Maharaj Singh Karen M. Michel Michael P. Mullane Husam S. Tarawneh Angi Kraut Kayla J. Hamm Follow this and additional works at: https://aurora.org/jpcrr Part of the Immune System Diseases Commons, Medical Immunology Commons, Neoplasms Commons, Oncology Commons, Public Health Education and Promotion Commons, and the Respiratory Tract Diseases Commons Recommended Citation Thompson MA, Oaks MK, Singh M, Michel KM, Mullane MP, Tarawneh HS, Kraut A, Hamm KJ. Multiple myeloma baseline immunoglobulin G level and pneumococcal vaccination antibody response. J Patient Cent Res Rev. 2017;4:131-5. doi: 10.17294/2330-0698.1453 Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes, and the patient experience. BRIEF REPORT Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response Michael A. Thompson, MD, PhD,1,3 Martin K. Oaks, PhD,2 Maharaj Singh, PhD,1 Karen M. Michel, BS,1 Michael P. Mullane,3 MD, Husam S. Tarawneh, MD,3 Angi Kraut, RN, BSN, OCN,1 Kayla J. Hamm, BSN3 1Aurora Research Institute, Aurora Health Care, Milwaukee, WI; 2Transplant Research Laboratory, Aurora St. Luke’s Medical Center, Aurora Health Care, Milwaukee, WI; 3Aurora Cancer Care, Aurora Health Care, Milwaukee, WI Abstract Infections are a major cause of morbidity and mortality in multiple myeloma (MM), a cancer of the immune system.
    [Show full text]
  • Opsonin-Dependent Stimulation of Bovine Neutrophil Oxidative Metabolism by Brucella Abortus Peter C
    Veterinary Microbiology and Preventive Medicine Veterinary Microbiology and Preventive Medicine Publications 2-1988 Opsonin-dependent stimulation of bovine neutrophil oxidative metabolism by Brucella abortus Peter C. Canning U.S. Department of Agriculture Billy L. Deyoe U.S. Department of Agriculture James A. Roth Iowa State University, [email protected] Follow this and additional works at: https://lib.dr.iastate.edu/vmpm_pubs Part of the Veterinary Microbiology and Immunobiology Commons, Veterinary Preventive Medicine, Epidemiology, and Public Health Commons, and the Veterinary Toxicology and Pharmacology Commons The ompc lete bibliographic information for this item can be found at https://lib.dr.iastate.edu/ vmpm_pubs/190. For information on how to cite this item, please visit http://lib.dr.iastate.edu/ howtocite.html. This Article is brought to you for free and open access by the Veterinary Microbiology and Preventive Medicine at Iowa State University Digital Repository. It has been accepted for inclusion in Veterinary Microbiology and Preventive Medicine Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Opsonin-dependent stimulation of bovine neutrophil oxidative metabolism by Brucella abortus Abstract Nonopsonized Brucella abortus and bacteria treated with fresh antiserum, heat-inactivated antiserum, or normal bovine serum were evaluated for their ability to stimulate production of superoxide anion and myeloperoxidasemediated iodination by neutrophils from cattle. Brucella abortus opsonized with fresh antiserum or beat-inactivated antiserum stimulated production of approximately 3 nmol of 0 2 -/106 neutrophils/30 min. Similarly treated bacteria also stimulated the binding of approximately 4.3 nmol of Nal/ 107 neutrophils/h to protein.
    [Show full text]
  • Complement Herbert L
    Host Defense 2011 Complement Herbert L. Mathews, Ph.D. COMPLEMENT Date: 4/11/11 Reading Assignment: Janeway’s Immunobiology, 7th Edition, pp. 54-55, 61-82, 406- 409, 514-515. Figures: (Unless otherwise noted) Janeway’s Immunobiology, 7th Edition, Murphy et al., Garland Publishing. KEY CONCEPTS AND LEARNING OBJECTIVES You will be able to describe the mechanism and consequences of the activation of the complement system. To attain the goals for these lectures you will be able to: a. List the components of the complement system. b. Describe the three activation pathways for complement. c. Explain the consequences of complement activation. d. Describe the consequence of complement deficiency. Page 1 Host Defense 2011 Complement Herbert L. Mathews, Ph.D. CONTENT SUMMARY Introduction Nomenclature Activation of Complement The classical pathway The mannan-binding lectin pathway The alternative pathway Biological Consequence of Complement Activation Cell lysis and viral neutralization Opsonization Clearance of Immune Complexes Inflammation Regulation of Complement Activation Human Complement Component Deficiencies Page 2 Host Defense 2011 Complement Herbert L. Mathews, Ph.D. Introduction The complement system is a group of more than 30 plasma and membrane proteins that play a critical role in host defense. When activated, complement components interact in a highly regulated fashion to generate products that: Recruit inflammatory cells (promoting inflammation). Opsonize microbial pathogens and immune complexes (facilitating antigen clearance). Kill microbial pathogens (via a lytic mechanism known as the membrane attack complex). Generate an inflammatory response. Complement activation takes place on antigenic surfaces. However, the activation of complement generates several soluble fragments that have important biologic activity.
    [Show full text]
  • ©Ferrata Storti Foundation
    Stem Cell Transplantation • Research Paper Rabbit-immunoglobulin G levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantation Mats Remberger Background and Objectives. The role of serum concentrations of rabbit antithymoglob- Berit Sundberg ulin (ATG) in the development of acute graft-versus-host disease (GVHD) after allogene- ic hematopoietic stem cell transplantation (HSCT) with unrelated donors is unknown. Design and Methods. We determined the serum concentration of rabbit immunoglobu- lin-G (IgG) using an enzyme linked immunosorbent assay in 61 patients after unrelat- ed donor HSCT. The doses of ATG ranged between 4 and 10 mg/kg. The conditioning consisted mainly of cyclophosphamide and total body irradiation or busulfan. Most patients received GVHD prophylaxis with cyclosporine and methotrexate. Results. The rabbit IgG levels varied widely in each dose group. The levels of rabbit IgG gradually declined and could still be detected up to five weeks after HSCT. We found a correlation between the grade of acute GVHD and the concentration of rabbit IgG in serum before the transplantation (p=0.017). Patients with serum levels of rabbit IgG >70 mg/mL before HSCT ran a very low risk of developing acute GVHD grades II-IV, as compared to those with levels <70 mg/mL (11% vs. 48%, p=0.006). Interpretations and Conclusions. The measurement of rabbit IgG levels in patients receiving ATG as prophylaxis against GVHD after HSCT may be of value in lowering the risk of severe GVHD. Key words: ATG, GVHD, BMT, thymoglobulin, rabbit-IgG. Haematologica 2005; 90:931-938 ©2005 Ferrata Storti Foundation From the Department of Clinical he outcomes of unrelated donor and rate of T-cell depletion.
    [Show full text]
  • Vaccine Immunology Claire-Anne Siegrist
    2 Vaccine Immunology Claire-Anne Siegrist To generate vaccine-mediated protection is a complex chal- non–antigen-specifc responses possibly leading to allergy, lenge. Currently available vaccines have largely been devel- autoimmunity, or even premature death—are being raised. oped empirically, with little or no understanding of how they Certain “off-targets effects” of vaccines have also been recog- activate the immune system. Their early protective effcacy is nized and call for studies to quantify their impact and identify primarily conferred by the induction of antigen-specifc anti- the mechanisms at play. The objective of this chapter is to bodies (Box 2.1). However, there is more to antibody- extract from the complex and rapidly evolving feld of immu- mediated protection than the peak of vaccine-induced nology the main concepts that are useful to better address antibody titers. The quality of such antibodies (e.g., their these important questions. avidity, specifcity, or neutralizing capacity) has been identi- fed as a determining factor in effcacy. Long-term protection HOW DO VACCINES MEDIATE PROTECTION? requires the persistence of vaccine antibodies above protective thresholds and/or the maintenance of immune memory cells Vaccines protect by inducing effector mechanisms (cells or capable of rapid and effective reactivation with subsequent molecules) capable of rapidly controlling replicating patho- microbial exposure. The determinants of immune memory gens or inactivating their toxic components. Vaccine-induced induction, as well as the relative contribution of persisting immune effectors (Table 2.1) are essentially antibodies— antibodies and of immune memory to protection against spe- produced by B lymphocytes—capable of binding specifcally cifc diseases, are essential parameters of long-term vaccine to a toxin or a pathogen.2 Other potential effectors are cyto- effcacy.
    [Show full text]
  • Histamine Metabolism in Cells of the Allergic Response
    PLATELET RESPONSE TO IMMUNOLOGICAL INJURY. J.G. White, R.M. INDUCTION OF ABNORMAL IMMUNOPOIESIS BY PERSISTENT EMBRYONIC Condie, and G.H.R. Rao. Univ. of Minn. School of Med., Mpls., VIRAL INFECTION. T. Yamauchi, J.1,!. St. GE, Jr., H.L. Itartin, Minn . D.C. Heiner and P1.D. Cooper. UCLA Sch. Ned. Ifarbor Gen. Bosp. Platelets are susceptible to immunological destruction, and Univ. Ala. Pled. Ctr., Depts. Ped., Torr. and Birmingham. but the nature of the immune lesion has not been defined. Infection of 16-hour-old chicken embryos with mumps virus Biochemistry, physiology, freeze-etching and electron micro- produced an initial decrease of both plasmalIgM and IgG in scopy were used to detect antibody induced injury. Antiserum poults with delayed maturation of normal IgG synthesis. De- (AS) was raised in a horse by repeated I.M. injections of spite hypogammaglobulinemia, specific antiviral neutralizing glutaraldehyde fixed human platelets. Absorbtion with PPP re- antibody first appeared one week after disappearance of virus moved non-specific activity of AS. The AS caused release of from 7-day-old hatchling chicks. serotonin to a dilution of 1:10,000 without producing ultra- Intramuscular inoculation of 13-day-old chicks with heter- structural damage. AS stimulated aggregation in stirred C-PRP ologous erythrocytes elicited significantly (P<.01) lower to a dilution of 1:1000. Aggregates resembled those produced titers of agglutinins in embryonically-infected birds with a by collagen. Lactic dehydrogenase was not discharged by dilu- delay in transition of 19s to 7S antibody. Secondary anti- tions greater than 1:10 . Dilutions to 1:100 caused platelet body surge in experimental birds was also significantly (P<.02) lysis and produced characteristic membrane lesions visible in less than controls with continued predominance of 19s antibody.
    [Show full text]
  • Activation of Human Complement by Immunoglobulin G Antigranulocyte Antibody
    Activation of human complement by immunoglobulin G antigranulocyte antibody. P K Rustagi, … , M S Currie, G L Logue J Clin Invest. 1982;70(6):1137-1147. https://doi.org/10.1172/JCI110712. Research Article The ability of antigranulocyte antibody to fix the third component of complement (C3) to the granulocyte surface was investigated by an assay that quantitates the binding of monoclonal anti-C3 antibody to paraformaldehyde-fixed cells preincubated with Felty's syndrome serum in the presence of human complement. The sera from 7 of 13 patients with Felty's syndrome bound two to three times as much C3 to granulocytes as sera from patients with uncomplicated rheumatoid arthritis. The complement-activating ability of Felty's syndrome serum seemed to reside in the monomeric IgG-containing serum fraction. For those sera capable of activating complement, the amount of C3 fixed to granulocytes was proportional to the amount of granulocyte-binding IgG present in the serum. Thus, complement fixation appeared to be a consequence of the binding of antigranulocyte antibody to the cell surface. These studies suggest a role for complement-mediated injury in the pathophysiology of immune granulocytopenia, as has been demonstrated for immune hemolytic anemia and immune thrombocytopenia. Find the latest version: https://jci.me/110712/pdf Activation of Human Complement by Immunoglobulin G Antigranulocyte Antibody PRADIP K. RUSTAGI, MARK S. CURRIE, and GERALD L. LOGUE, Departments of Medicine, Duke University and Durham Veterans Administration Medical Centers,
    [Show full text]
  • Mast Cells in Infection and Immunity†
    INFECTION AND IMMUNITY, Sept. 1997, p. 3501–3508 Vol. 65, No. 9 0019-9567/97/$04.0010 Copyright © 1997, American Society for Microbiology MINIREVIEW Mast Cells in Infection and Immunity† 1,2 2 SOMAN N. ABRAHAM * AND RAVI MALAVIYA Departments of Pathology and Molecular Microbiology, Washington University School of Medicine,1 and Department of Pathology, Barnes-Jewish Hospital of St. Louis,2 St. Louis, Missouri 63110 Mast cells remain one of the most enigmatic cells in the mediates binding of mast cells to parasitic helminths (46). body. These cells secrete significant amounts of numerous Parasitic helminths evoke a specific humoral immune response proinflammatory mediators which contribute to a number of in the host which involves, at least in part, the secretion of a chronic inflammatory conditions, including stress-induced in- large number of IgE antibodies (46). These antibodies become testinal ulceration, rheumatoid arthritis, interstitial cystitis, attached to mast cell surfaces because of the numerous IgE scleroderma, and Crohn’s disease (6, 14, 24, 76). Mast cells are receptors (FcεR) present on mast cell plasma membranes. also prominent in the development of anaphylaxis (14, 24, 76). Those IgE molecules that are specific for helminths then pro- Yet despite the negative effects of their secretions, mast cells mote mast cell binding to the parasite (56). Although IgE is not or mast cell-like cells have been described even among the commonly generated against bacteria, IgE specific to Helico- lowest order of animals (31). The phylogenic persistence of bacter pylori and Staphylococcus aureus has been reported in these cells through evolution strongly suggests that they are patients with peptic ulcers and atopic dermatitis, respectively beneficial in some fashion to the host.
    [Show full text]
  • Innate Immunity
    INNATE IMMUNITY RAKESH SHARDA Department of Veterinary Microbiology NDVSU College of Veterinary Science & A.H., Mhow Innate Immunity - characteristics • Most primitive type of immune system found in virtually all multicellular animals • high discrimination of host and pathogen • First line of defense against infection • no need for prolonged induction • act quickly immediate direct response 0-4 hrs rapid induced 4-96 hrs • antigen-independent Innate Immunity – characteristics (contd.) • dependence on germ line encoded receptors • always present and active, constitutively expressed (some components can be up-regulated) • Nonspecific; not specifically directed against any particular infectious agent or tumor • no clonal expansion of Ag specificity • Same every time; no ‘memory’ as found in the adaptive immune system • failure ==> adaptive immune response Components of Innate Immunity First line Second line 1 Physical barriers A- cells 2 Chemical & biochemical barriers 1- Natural killer 3 Biological barriers (Normal flora) 2- Phagocytes 3- inflammatory cells B- Soluble factors C- Inflammatory barriers Anatomical /Physical/Mechanical Barriers System or Organ Cell type Mechanism Skin Squamous epithelium Physical barrier (intact skin) Desquamation Mucous Membranes Non-ciliated epithelium (e.g. Peristalsis GI tract) Ciliated epithelium, hairs Mucociliary elevator, (e.g. respiratory tract) Coughing, sneezing Epithelium (e.g. Flushing action of nasopharynx) tears, saliva, mucus, urine; blinking of eye lids Biological Factors System or Organ Component
    [Show full text]